While I would not deny that some of yesterday’s trading may have been shorting, as has been speculated, I would also be willing to bet that quite a bit of selling was from those who owned shares but want to participate in the financing. Pretty good deal if you could sell in the $3.70 range (yesterday’s average trade was at $3.73) and put some or all of those proceeds into $4 units that give you one share plus one warrant. This allows an investor to either maintain their call (total shares plus warrants) on RVX and take some money off the table or increase their total call on RVX for the same money.  In June of 2017 when RVX last completed a BB financing the two largest net sellers around that trade were sellers through Raymond James and Anonymous, yesterday was the same by a wide margin. (RJ -217 k shares, 001 -134k shares) Coincidence? The next biggest net sellers were through ITG (-84k shares) Anonymous and ITG are generally pros. 

I’m sure there was also a lot of fear based selling by retailers as well which is understandable given that the last two adventures with Bloom Burton have not worked out well for the share price in the short/medium term. 

As far as investors tanking the stock because they are unhappy with the potential dilution of this financing, to me that is just nonsense.  Selling 5 to 10 million units has potential dilution of 5 to 10 percent (on a fully diluted basis) which is insignificant imo.  

Circling back to the shorts, I think the chances at this point that someone has knowledge of trial failure are incredibly small given that I doubt if enough data has been summarized to give a clear picture. It will be interesting to see the short numbers this time around. Imo you have to be pretty bold to short RVX at this stage. If BoM doesn’t give us what we are looking for the stock will be hit and money could be made for sure but if BoM succeeds the losses for a short could far exceed the potential money to be made.

Jmo